Sequence of CFAI_HUMAN

complement factor I

P05156

583

65750

400724

Catterall C.F.,Lyons A.,Sim R.M.,Day A.J.,Harris T.J.R.

Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.

Biochem. J.

242

849-856

1987

400725

Goldberger G.,Bruns G.A.P.,Rits M.,Edge M.D.,Kwiatkowski D.J.

Human complement factor I: analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4.

J. Biol. Chem.

262

10065-10071

1987

400726

Hillier L.W.,Graves T.A.,Fulton R.S.,Fulton L.A.,Pepin K.H.,Minx P.,Wagner-McPherson C.,Layman D.,Wylie K.,Sekhon M.,Becker M.C.,Fewell G.A.,Delehaunty K.D.,Miner T.L.,Nash W.E.,Kremitzki C.,Oddy L.,Du H.,Sun H.,Bradshaw-Cordum H.,Ali J.,Carter J.,Cordes M.,Harris A.,Isak A.,van Brunt A.,Nguyen C.,Du F.,Courtney L.,Kalicki J.,Ozersky P.,Abbott S.,Armstrong J.,Belter E.A.,Caruso L.,Cedroni M.,Cotton M.,Davidson T.,Desai A.,Elliott G.,Erb T.,Fronick C.,Gaige T.,Haakenson W.,Haglund K.,Holmes A.,Harkins R.,Kim K.,Kruchowski S.S.,Strong C.M.,Grewal N.,Goyea E.,Hou S.,Levy A.,Martinka S.,Mead K.,McLellan M.D.,Meyer R.,Randall-Maher J.,Tomlinson C.,Dauphin-Kohlberg S.,Kozlowicz-Reilly A.,Shah N.,Swearengen-Shahid S.,Snider J.,Strong J.T.,Thompson J.,Yoakum M.,Leonard S.,Pearman C.,Trani L.,Radionenko M.,Waligorski J.E.,Wang C.,Rock S.M.,Tin-Wollam A.-M.,Maupin R.,Latreille P.,Wendl M.C.,Yang S.-P.,Pohl C.,Wallis J.W.,Spieth J.,Bieri T.A.,Berkowicz N.,Nelson J.O.,Osborne J.,Ding L.,Meyer R.,Sabo A.,Shotland Y.,Sinha P.,Wohldmann P.E.,Cook L.L.,Hickenbotham M.T.,Eldred J.,Williams D.,Jones T.A.,She X.,Ciccarelli F.D.,Izaurralde E.,Taylor J.,Schmutz J.,Myers R.M.,Cox D.R.,Huang X.,McPherson J.D.,Mardis E.R.,Clifton S.W.,Warren W.C.,Chinwalla A.T.,Eddy S.R.,Marra M.A.,Ovcharenko I.,Furey T.S.,Miller W.,Eichler E.E.,Bork P.,Suyama M.,Torrents D.,Waterston R.H.,Wilson R.K.

Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

Nature

434

724-731

2005

400727

Minta J.O.,Fung M.,Turner S.,Eren R.,Zemach L.,Rits M.,Goldberger G.

Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene.

Gene

208

17-24

1998

400728

Whaley K.

Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

J. Exp. Med.

151

501-516

1980

400729

Harrison R.A.,Lachmann P.J.

The physiological breakdown of the third component of human complement.

Mol. Immunol.

17

9-20

1980

400730

Goldberger G.,Arnaout M.A.,Aden D.,Kay R.,Rits M.,Colten H.R.

Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines.

J. Biol. Chem.

259

6492-6497

1984

400731

Seya T.,Okada M.,Nishino H.,Atkinson J.P.

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.

J. Biochem.

107

310-315

1990

400732

Ullman C.G.,Haris P.I.,Smith K.F.,Sim R.B.,Emery V.C.,Perkins S.J.

Beta-sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopy.

FEBS Lett.

371

199-203

1995

400733

Soames C.J.,Sim R.B.

Interactions between human complement components factor H, factor I and C3b.

Biochem. J.

326

553-561

1997

400734

Sahu A.,Isaacs S.N.,Soulika A.M.,Lambris J.D.

Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.

J. Immunol.

160

5596-5604

1998

400735

Barilla-LaBarca M.L.,Liszewski M.K.,Lambris J.D.,Hourcade D.,Atkinson J.P.

Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.

J. Immunol.

168

6298-6304

2002

400736

Bunkenborg J.,Pilch B.J.,Podtelejnikov A.V.,Wisniewski J.R.

Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.

Proteomics

4

454-465

2004

400737

Liu T.,Qian W.-J.,Gritsenko M.A.,Camp D.G. II,Monroe M.E.,Moore R.J.,Smith R.D.

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

J. Proteome Res.

4

2070-2080

2005

400738

Timar K.K.,Junnikkala S.,Dallos A.,Jarva H.,Bhuiyan Z.A.,Meri S.,Bos J.D.,Asghar S.S.

Human keratinocytes produce the complement inhibitor factor I: Synthesis is regulated by interferon-gamma.

Mol. Immunol.

44

2943-2949

2007

400739

Hair P.S.,Ward M.D.,Semmes O.J.,Foster T.J.,Cunnion K.M.

Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.

J. Infect. Dis.

198

125-133

2008

400740

Chen R.,Jiang X.,Sun D.,Han G.,Wang F.,Ye M.,Wang L.,Zou H.

Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.

J. Proteome Res.

8

651-661

2009

400741

Jia W.,Lu Z.,Fu Y.,Wang H.P.,Wang L.H.,Chi H.,Yuan Z.F.,Zheng Z.B.,Song L.N.,Han H.H.,Liang Y.M.,Wang J.L.,Cai Y.,Zhang Y.K.,Deng Y.L.,Ying W.T.,He S.M.,Qian X.H.

A strategy for precise and large scale identification of core fucosylated glycoproteins.

Mol. Cell. Proteomics

8

913-923

2009

400742

Nilsson J.,Rueetschi U.,Halim A.,Hesse C.,Carlsohn E.,Brinkmalm G.,Larson G.

Enrichment of glycopeptides for glycan structure and attachment site identification.

Nat. Methods

6

809-811

2009

400743

Roversi P.,Johnson S.,Caesar J.J.,McLean F.,Leath K.J.,Tsiftsoglou S.A.,Morgan B.P.,Harris C.L.,Sim R.B.,Lea S.M.

Structural basis for complement factor I control and its disease-associated sequence polymorphisms.

Proc. Natl. Acad. Sci. U.S.A.

108

12839-12844

2011

400744

Xue X.,Wu J.,Ricklin D.,Forneris F.,Di Crescenzio P.,Schmidt C.Q.,Granneman J.,Sharp T.H.,Lambris J.D.,Gros P.

Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses.

Nat. Struct. Mol. Biol.

24

643-651

2017

400745

Vyse T.J.,Morley B.J.,Bartok I.,Theodoridis E.L.,Davies K.A.,Webster A.D.B.,Walport M.J.

The molecular basis of hereditary complement factor I deficiency.

J. Clin. Invest.

97

925-933

1996

400746

Baracho G.V.,Nudelman V.,Isaac L.

Molecular characterization of homozygous hereditary factor I deficiency.

Clin. Exp. Immunol.

131

280-286

2003

400747

Fremeaux-Bacchi V.,Dragon-Durey M.-A.,Blouin J.,Vigneau C.,Kuypers D.,Boudailliez B.,Loirat C.,Rondeau E.,Fridman W.H.

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.

J. Med. Genet.

41

0-0

2004

400748

Caprioli J.,Noris M.,Brioschi S.,Pianetti G.,Castelletti F.,Bettinaglio P.,Mele C.,Bresin E.,Cassis L.,Gamba S.,Porrati F.,Bucchioni S.,Monteferrante G.,Fang C.J.,Liszewski M.K.,Kavanagh D.,Atkinson J.P.,Remuzzi G.

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Blood

108

1267-1279

2006

400749

Servais A.,Fremeaux-Bacchi V.,Lequintrec M.,Salomon R.,Blouin J.,Knebelmann B.,Gruenfeld J.-P.,Lesavre P.,Noeel L.-H.,Fakhouri F.

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

J. Med. Genet.

44

193-199

2007

400750

Geelen J.,van den Dries K.,Roos A.,van de Kar N.,de Kat Angelino C.,Klasen I.,Monnens L.,van den Heuvel L.

A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.

Pediatr. Nephrol.

22

371-375

2007

400751

Maga T.K.,Nishimura C.J.,Weaver A.E.,Frees K.L.,Smith R.J.H.

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Hum. Mutat.

31

0-0

2010

400752

van de Ven J.P.,Nilsson S.C.,Tan P.L.,Buitendijk G.H.,Ristau T.,Mohlin F.C.,Nabuurs S.B.,Schoenmaker-Koller F.E.,Smailhodzic D.,Campochiaro P.A.,Zack D.J.,Duvvari M.R.,Bakker B.,Paun C.C.,Boon C.J.,Uitterlinden A.G.,Liakopoulos S.,Klevering B.J.,Fauser S.,Daha M.R.,Katsanis N.,Klaver C.C.,Blom A.M.,Hoyng C.B.,den Hollander A.I.

A functional variant in the CFI gene confers a high risk of age-related macular degeneration.

Nat. Genet.

45

813-817

2013

400753

Bian Y.,Song C.,Cheng K.,Dong M.,Wang F.,Huang J.,Sun D.,Wang L.,Ye M.,Zou H.

An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

J. Proteomics

96

253-262

2014